Dergiler / art / 2014 / Cilt: 29 - Sayı: 1

Differential diagnosis of anemia in patients with rheumatoid arthritis

Dergi
art
Sayfa
42–46
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A differential diagnosis of anemia in patients with RA should be based on determining the serum iron and ferritin levels as well as the presence of relative EPO deficiency.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study aims to identify laboratory markers which can be used to distinguish between the different types of anemia in patients with rheumatoid arthritis (RA).
📊
Temel Bulgular & Veri:Iron deficiency anemia (IDA) was defined as serum ferritin levels of <15 ng/ml) together with low serum iron levels (IDA group) while anemia of chronic disease (ACD) was defined as having serum ferritin levels of >15 ng/ml and normal serum iron levels (ACD group).
💡
Sonuç & Katkı:A differential diagnosis of anemia in patients with RA should be based on determining the serum iron and ferritin levels as well as the presence of relative EPO deficiency.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: This study aims to identify laboratory markers which can be used to distinguish between the different types of anemia in patients with rheumatoid arthritis (RA). Patients and methods: Ninety patients who met the American College of Rheumatology (ACR) criteria for RA and the World Health Organization (WHO) criteria for anemia were included in this study. We evaluated the hematocrit, color index, serum iron, ferritin, transferrin, and erythropoietin (EPO) levels along with the total iron binding capacity (TIBC) and mean erythrocyte volumes. Iron deficiency anemia (IDA) was defined as serum ferritin levels of <15 ng/ml) together with low serum iron levels (IDA group) while anemia of chronic disease (ACD) was defined as having serum ferritin levels of >15 ng/ml and normal serum iron levels (ACD group). Those with low serum iron and low/normal ferritin levels were included in the COMBI group, a combination of IDA and ACD (COMBI group). Results: The serum ferritin concentration was significantly increased and the serum transferrin level was significantly decreased in the IDA group compared with the ACD and COMBI groups. We also observed elevated EPO concentrations in all of the subgroups, but we found relative EPO deficiency only in the ACD and COMBI groups. Conclusion: Our findings suggest that the characte-ristics of COMBI anemia encompass the qualities of both ACD and IDA, particularly the latter. A differential diagnosis of anemia in patients with RA should be based on determining the serum iron and ferritin levels as well as the presence of relative EPO deficiency.

🔖

Bu Makaleye Atıf Yap

VATUTIN, M., SMYRNOVA, G., SHEVELYOK, A., KASHANSKA, O., SKLYANNA, O., KETİNG, O. (2014). Differential diagnosis of anemia in patients with rheumatoid arthritis. art, Cilt: 29 - Sayı: 1, 42–46. https://ajindex.com/articles/200486

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Neumann E, Lefèvre S, Zimmermann B, Gay S, Müller- Ladner U. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 2010;16:458–68
  2. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907–16
  3. Bloxham E, Vagadia V, Scott K, Francis G, Saravanan V, Heycock C, et al. Anaemia in rheumatoid arthritis: can we afford to ignore it? Postgrad Med J 2011;87:596–600
  4. Kullich W, Niksic F, Burmucic K, Pöllmann G, Klein G. Effects of the chemokine MIP-1alpha on anemia and inflammation in rheumatoid arthritis. Z Rheumatol 2002;61:568–76
  5. Iron deficiency anaemia. Assessment, prevention and control. A guide for programme managers. World Health Organization, Document WHO/NHD/01.3, Geneva; 2001. p. 115
  6. Osterborg A, Boogaerts MA, Cimino R, Essers U, Holowiecki J, Juliusson G, et al. Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin’s Lymphoma. Blood 1996;87:2675–82
  7. Ogedegbe H, Csury L, Simmons B. Anemias: A clinical laboratory perspective. Lab Medicine 2004;35:177–85
  8. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002;100:3776–81.